ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 717859 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 717859; 2) Community: the network communities that were significantly associated with the response to NSC 717859; 3) Molecule: the relationships between components within communities and NSC 717859; 4) MDR: the compounds that were significantly associated with the NSC 717859.

NSC Compound Enrichment Correlation
NSC 3074 s-Triazine, 4,6-diamino-1-(p-chlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.00678797485541278 0.054539715
NSC 624227 Null 0.00678797485541278 -0.18874983
NSC 633116 Null 0.00678797485541278 -0.078807377
NSC 646859 Null 0.00678797485541278 0.18103733
NSC 648263 Null 0.00678797485541278 -0.25833154
NSC 710416 Null 0.00678797485541278 -0.021813628
NSC 80466 1H-Naphth[2,3-d]imidazolium, 4,9-dihydro-1,2-dimethyl-3-(2-methylpropyl)-4,9-dioxo-, iodide 0.00678797485541278 -0.08655943
NSC 107124 Camptothecin Derivative 0.0072542482863368 -0.055119856
NSC 143147 Urea, 1,1'-(methylenedi-4,1-cyclohexylene)bis[3-(2-chloroethyl)-3-nitroso- (8CI) 0.0072542482863368 -0.16993531
NSC 364830 Camptothecin Derivative 0.0072542482863368 -0.01641491
Total:57  Current:11    [First] [Prev] [Next] [Last]